STOCK TITAN

NuSkin Enterprises, Inc. - NUS STOCK NEWS

Welcome to our dedicated page for NuSkin Enterprises news (Ticker: NUS), a resource for investors and traders seeking the latest updates and insights on NuSkin Enterprises stock.

Nu Skin Enterprises, Inc. (NYSE: NUS) is a global leader in health and beauty, founded 35 years ago. The company excels in creating and distributing innovative consumer products, focusing on beauty and wellness. Nu Skin’s product lines include personal care items under the Nu Skin brand and nutritional supplements marketed under the Pharmanex brand. Operating in more than 50 countries, the firm’s extensive reach reflects its robust international presence.

Nu Skin Enterprises encompasses several companies such as Nu Skin, Groviv, Wasatch Labs, Elevate Health Sciences, and Casepak. This diverse portfolio enables the company to offer a wide range of products and services, from consumer goods to advanced manufacturing and controlled environment agriculture technologies.

In recent developments, Nu Skin has shown a commitment to innovation and growth. In October 2023, the company announced the release of its third quarter financial results, revealing both challenges and growth opportunities. Despite economic hurdles, particularly in Mainland China and the Americas, Nu Skin experienced stabilization and growth in regions like Europe and Africa. The introduction of new products, such as the ageLOC® WellSpa iO™ and an upcoming mental wellness category in 2024, showcases the firm’s dedication to expanding its offerings and driving long-term success.

In November 2023, Nu Skin celebrated the opening of a new manufacturing facility in Shanghai, China, an investment of approximately $55 million. This facility exemplifies the company's commitment to enhancing production capacity and supply chain efficiency, particularly in Asian markets. The plant uses Industry 4.0 standards, featuring smart systems and real-time data analysis, further underlining Nu Skin’s focus on technological advancement and sustainability.

Additionally, in February 2024, Nu Skin introduced the RenuSpa iO, a smart device designed to promote skin health and body confidence. This FDA-cleared device embodies the latest in microcurrent technology, offering personalized beauty and wellness solutions. The Nu Skin Vera® app enhances the user experience by providing real-time data insights and guided tutorials.

Financial Overview: As of the latest updates, Nu Skin’s projected 2023 revenue is between $1.92 and $1.96 billion, with an expected EPS of $(0.10) to $0.05 or adjusted EPS of $1.62 to $1.77, excluding significant charges. The company’s strategic initiatives, including cost management and product portfolio optimization, aim to drive future growth and profitability.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
dividends
-
Rhea-AI Summary
Rhyz Inc., a subsidiary of Nu Skin Enterprises, has acquired BeautyBio, a skincare and beauty device brand. BeautyBio will continue to operate independently and leverage growth opportunities as part of the Rhyz ecosystem.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
-
Rhea-AI Summary
Nu Skin Enterprises, Inc. (NYSE: NUS) appoints James D. Thomas as executive vice president and chief financial officer. Thomas, who has been serving as interim CFO for the past four months, brings extensive experience and expertise in financial operations and strategic alignment to support the company's vision for the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
management
Rhea-AI Summary
Nu Skin Enterprises, Inc. will release its second quarter 2023 results on August 1. The management team will host a conference call at 5 p.m. ET on the same day to discuss recent results and upcoming business initiatives. The webcast of the conference call will be available on the company's investor relations page. A replay of the webcast will be available until August 15.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.43%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.37%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.32%
Tags
dividends
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.73%
Tags
none
-
Rhea-AI Summary

Nu Skin Enterprises (NYSE: NUS) announced the resignation of CFO Mark Lawrence, effective March 31, 2023, to pursue other opportunities. Lawrence will continue as a senior advisor until April 2023 to ensure a smooth transition. The board has appointed James D. Thomas, previously the chief accounting officer, as interim CFO while searching for a permanent replacement. The company reaffirmed its first-quarter and annual guidance for 2023, initially provided on February 15, 2023. Nu Skin will release its Q1 results on May 3, 2023, followed by a conference call with investors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
management
Rhea-AI Summary

Nu Skin Enterprises, Inc. (NYSE: NUS) reported Q4 2022 revenue of $522.3 million, down 22% year-over-year, impacted by foreign exchange (FX) losses of $51 million. EPS for the quarter was $1.15, improving from a loss of $(0.18) in Q4 2021. For FY 2022, revenue totaled $2.23 billion, down 17%. Looking ahead, Q1 2023 revenue is projected between $450 to $490 million, a decline of 26% to 19%. Annual revenue guidance for 2023 ranges from $2.03 billion to $2.18 billion. The company anticipates ongoing macroeconomic challenges but remains optimistic about its long-term strategy and growth prospects.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.21%
Tags

FAQ

What is the current stock price of NuSkin Enterprises (NUS)?

The current stock price of NuSkin Enterprises (NUS) is $7.53 as of January 3, 2025.

What is the market cap of NuSkin Enterprises (NUS)?

The market cap of NuSkin Enterprises (NUS) is approximately 399.2M.

What does Nu Skin Enterprises, Inc. do?

Nu Skin Enterprises, Inc. is a global health and beauty company that develops and distributes personal care and nutritional products under the Nu Skin and Pharmanex brands. It operates in over 50 countries.

When was Nu Skin Enterprises, Inc. founded?

Nu Skin Enterprises, Inc. was founded 35 years ago.

What is the ticker symbol for Nu Skin Enterprises, Inc.?

The ticker symbol for Nu Skin Enterprises, Inc. is NUS, traded on the New York Stock Exchange.

What were the recent financial results for Nu Skin Enterprises, Inc.?

Nu Skin reported softer-than-expected third quarter 2023 results due to macro-economic challenges, with a projected annual revenue of $1.92 to $1.96 billion and an EPS of $(0.10) to $0.05 or adjusted EPS of $1.62 to $1.77.

What is the ageLOC® WellSpa iO™?

The ageLOC® WellSpa iO™ is a smart device system by Nu Skin designed to promote holistic wellness and beauty. It represents one of the company’s latest innovations in personal care.

What is the significance of the new manufacturing facility in China for Nu Skin?

The new facility in Shanghai, China, represents a $55 million investment to increase production capacity and supply chain responsiveness in Asian markets. It uses Industry 4.0 standards for enhanced efficiency.

What is RenuSpa iO?

RenuSpa iO is a smart beauty and wellness device introduced by Nu Skin. It uses adaptive microcurrent technology to improve skin health and body confidence through personalized treatments.

Who are the members of the Nu Skin Enterprises family?

The Nu Skin Enterprises family includes Nu Skin, Groviv, Wasatch Labs, Elevate Health Sciences, and Casepak.

How does Nu Skin contribute to sustainability?

Nu Skin focuses on sustainable solutions in its operations, including the use of controlled environment agriculture technology and green building standards in its new manufacturing facilities.

What is the Nu Skin Vera® app?

The Nu Skin Vera® app pairs with Nu Skin devices to provide users with live data insights, guided tutorials, and a library of routines for an enhanced, personalized beauty and wellness experience.
NuSkin Enterprises, Inc.

NYSE:NUS

NUS Rankings

NUS Stock Data

399.18M
47.31M
2.29%
80.56%
3.25%
Household & Personal Products
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
PROVO